Milestone Pharmaceuticals earnings were -$41.5M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest MIST earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$12.4M, up 31% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MIST reported annual earnings of -$41.5M, with -30.4% growth. The next MIST earnings date is May 12, 2025.
Milestone Pharmaceuticals Earnings Reports & History FAQ
What were Milestone Pharmaceuticals's earnings last quarter?
On MIST's earnings call on Invalid Date, Milestone Pharmaceuticals (NASDAQ: MIST) reported Q4 2024 earnings per share (EPS) of -$0.19, up 40.63% year over year. Total MIST earnings for the quarter were -$12.36 million. In the same quarter last year, Milestone Pharmaceuticals's earnings per share (EPS) was -$0.32.
When does Milestone Pharmaceuticals report earnings?
The next MIST earnings call is Invalid Date. Add MIST to your watchlist to be reminded of Milestone Pharmaceuticals's next earnings date.
What was MIST's earnings growth in the past year?
As of Milestone Pharmaceuticals's earnings date in Invalid Date, Milestone Pharmaceuticals's earnings has grown year over year. MIST earnings in the past year totalled -$41.52 million.
Is Milestone Pharmaceuticals profitable or losing money?
As of the last Milestone Pharmaceuticals earnings report, Milestone Pharmaceuticals is currently losing money. Milestone Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$41.52 million, a 30.44% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.